Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5382582 | 0.94 | — | — | |
| SCHEMBL121695 | 0.94 | — | — | |
| SCHEMBL1560310 | 0.94 | CA1 (0.86) | — | |
| Hydrogen Sulfide SCHEMBL1276869 | 0.88 | CA1 (0.75) | — | |
| SCHEMBL15864291 | 0.88 | CA1 (0.75) | — | |
| SCHEMBL15864274 | 0.88 | CA1 (0.75) | — | |
| SCHEMBL15864347 | 0.88 | CA1 (0.75) | — | |
| SCHEMBL16703451 | 0.88 | — | — | |
| SCHEMBL3243495 | 0.88 | CA1 (0.75) | — | |
| SCHEMBL16531901 | 0.88 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116621900-B | Tetravalent platinum aminohexose complex based on regulation and control of Mucin type O-glycosylation targeting CRPC and application thereof | 河南大学 | 2024-05-07 | — | — | CN | claimed |
| CN-116621900-A | Tetravalent platinum aminohexose complex based on regulation and control of Mucin type O-glycosylation targeting CRPC and application thereof | 河南大学 | 2023-08-22 | — | — | CN | claimed |
| CN-115632310-A | High-voltage solid soft starting cabinet with heat dissipation function | 襄阳忠东机电设备有限公司 | 2023-01-20 | — | — | CN | claimed |
| US-20250091050-A1 | OPTIMIZED SEQUENCING SYSTEMS AND METHODS | ULTIMA GENOMICS INC (US) | 2025-03-20 | — | — | US | disclosed |
| CN-116621900-B | Tetravalent platinum aminohexose complex based on regulation and control of Mucin type O-glycosylation targeting CRPC and application thereof | 河南大学 | 2024-05-07 | — | — | CN | disclosed |
| WO-2023192403-A2 | OPTIMIZED SEQUENCING SYSTEMS AND METHODS | ULTIMA GENOMICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| CN-116621900-A | Tetravalent platinum aminohexose complex based on regulation and control of Mucin type O-glycosylation targeting CRPC and application thereof | 河南大学 | 2023-08-22 | — | — | CN | disclosed |
| US-20230128195-A1 | SYNTHESIS OF HALICHONDRINS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-04-27 | — | — | US | disclosed |
| EP-4169924-A2 | SYNTHESIS OF HALICHONDRINS | President And Fellows Of Harvard College (US) | 2023-04-26 | — | — | EP | disclosed |
| US-11548898-B2 | Synthesis of halichondrins | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-01-10 | — | — | US | disclosed |
| EP-3649135-B1 | SYNTHESIS OF HALICHONDRINS | HARVARD COLLEGE (US) | 2022-12-28 | — | — | EP | disclosed |
| US-20210230177-A1 | SYNTHESIS OF HALICHONDRINS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-07-29 | — | — | US | disclosed |
| EP-3649135-A1 | SYNTHESIS OF HALICHONDRINS | President and Fellows of Harvard College (US) | 2020-05-13 | — | — | EP | disclosed |
| WO-2019010363-A1 | SYNTHESIS OF HALICHONDRINS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2019-01-10 | — | — | WO | disclosed |
| CN-105263921-B | Terazololine-one compound and its application | 住友化学株式会社 | 2017-07-21 | — | — | CN | disclosed |
| US-8617834-B2 | Thromboplastin reagent with long-term stability | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) | 2013-12-31 | — | — | US | disclosed |
| US-20090182140-A1 | Alicyclic Heterocyclic Compound | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2009-07-16 | — | — | US | disclosed |
| US-20090162880-A1 | THROMBOPLASTIN REAGENT WITH LONG-TERM STABILITY | SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH (DE) | 2009-06-25 | — | — | US | disclosed |
| EP-1970373-A1 | ALICYCLIC HETEROCYCLIC COMPOUND | Mitsubishi Tanabe Pharma Corporation (JP) | 2008-09-17 | — | — | EP | disclosed |